Trial NCT04678739
Publication Mohiuddin Chowdhury ATM, Front pharmacol (2022) (published paper)
Primary outcome on the report: Primary outcome was unclear. "Treatment outcomes were measured as follows: time to clinical improvement, defined as the time from randomization to NEWS-2 score (National Early Warning Score 2) of ≤2 as maintained for 24 h; mortality rate; duration of ICU stay; total period of hospitalization; the rate of oxygen use; time to clinical failure; NEWS-2 score on discharge; and the percentage of lung recovery on CT of the chest (the difference value of the CT involvement of lung pathology during admission and at the time of discharge)."

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.